OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GQ8YV05

Real-time BOERSE MUENCHEN 09:56:38 21/06/2024 pm IST
4.61 EUR -4.55% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+4.77%
1 month+24.16%
Date Price Change
21/24/21 4.61 -4.55%
20/24/20 4.83 -13.29%
19/24/19 5.57 +5.09%
18/24/18 5.3 +5.16%
17/24/17 5.04 +2.65%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 09:56 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ8YV0
ISINDE000GQ8YV05
Date issued 14/11/2023
Strike 291.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.76
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.99
Lowest since issue 0.92
Spread 0.03
Spread %0.65%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.4 USD
Average target price
372.9 USD
Spread / Average Target
+9.25%
Consensus